{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:56:10Z","timestamp":1790139370267,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cll.2018.07.007","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T18:50:47Z","timestamp":1538765447000},"page":"655-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Role of Human Leukocyte Antigen in Celiac Disease Diagnostics"],"prefix":"10.1016","volume":"38","author":[{"given":"Eszter","family":"L\u00e1z\u00e1r-Moln\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.cll.2018.07.007_bib1","first-page":"5300","article-title":"Origin of celiac disease: how old are predisposing haplotypes?","volume":"18","author":"Gasbarrini","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cll.2018.07.007_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1651-2227.1953.tb05586.x","article-title":"Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease","volume":"42","author":"Van De Kamer","year":"1953","journal-title":"Acta Paediatr"},{"issue":"7726","key":"10.1016\/j.cll.2018.07.007_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(71)92248-3","article-title":"Anti-reticulin antibodies in childhood coeliac disease","volume":"2","author":"Seah","year":"1971","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cll.2018.07.007_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jmg.36.9.687","article-title":"Contribution of the MHC region to the familial risk of coeliac disease","volume":"36","author":"Bevan","year":"1999","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.cll.2018.07.007_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.169.1.345","article-title":"Evidence for a primary association of celiac disease to a particular HLA-DQ alpha\/beta heterodimer","volume":"169","author":"Sollid","year":"1989","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"10.1016\/j.cll.2018.07.007_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nri885","article-title":"Coeliac disease: dissecting a complex inflammatory disorder","volume":"2","author":"Sollid","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"10.1016\/j.cll.2018.07.007_bib7","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra0808284","article-title":"Genetics of type 1A diabetes","volume":"360","author":"Concannon","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cll.2018.07.007_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0198-8859(03)00027-2","article-title":"HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease","volume":"64","author":"Karell","year":"2003","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.cll.2018.07.007_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2011.11.021","article-title":"T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease","volume":"142","author":"Bodd","year":"2012","journal-title":"Gastroenterology"},{"issue":"42","key":"10.1016\/j.cll.2018.07.007_bib10","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cll.2018.07.007_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.163.3.286","article-title":"Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study","volume":"163","author":"Fasano","year":"2003","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.cll.2018.07.007_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2012.06.006","article-title":"Celiac disease: an immunological jigsaw","volume":"36","author":"Meresse","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cll.2018.07.007_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.0001-2815.2004.00237.x","article-title":"HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease","volume":"63","author":"Margaritte-Jeannin","year":"2004","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.cll.2018.07.007_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1399-0039.1993.tb01998.x","article-title":"On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201","volume":"41","author":"Ploski","year":"1993","journal-title":"Tissue Antigens"},{"issue":"21","key":"10.1016\/j.cll.2018.07.007_bib15","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1073\/pnas.2135229100","article-title":"The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T\u00a0cell responses","volume":"100","author":"Vader","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"9","key":"10.1016\/j.cll.2018.07.007_bib16","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.cgh.2009.05.028","article-title":"Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles","volume":"7","author":"Pietzak","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cll.2018.07.007_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMoa1313977","article-title":"Risk of pediatric celiac disease according to HLA haplotype and country","volume":"371","author":"Liu","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2018.07.007_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng2058","article-title":"A\u00a0genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21","volume":"39","author":"van Heel","year":"2007","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.cll.2018.07.007_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrg1489","article-title":"Gene map of the extended human MHC","volume":"5","author":"Horton","year":"2004","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1016\/j.cll.2018.07.007_bib20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/gut.2005.083964","article-title":"Concordance, disease progression, and heritability of coeliac disease in Italian twins","volume":"55","author":"Nistico","year":"2006","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.cll.2018.07.007_bib21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.998","article-title":"Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease","volume":"43","author":"Trynka","year":"2011","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.cll.2018.07.007_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tig.2016.02.003","article-title":"Understanding celiac disease by genomics","volume":"32","author":"Withoff","year":"2016","journal-title":"Trends Genet"},{"issue":"4","key":"10.1016\/j.cll.2018.07.007_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00281-012-0312-1","article-title":"From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases","volume":"34","author":"Kumar","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"10","key":"10.1016\/j.cll.2018.07.007_bib24","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ni.1780","article-title":"Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation","volume":"10","author":"Fallang","year":"2009","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.cll.2018.07.007_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri1805","article-title":"MHC class II proteins and disease: a structural perspective","volume":"6","author":"Jones","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cll.2018.07.007_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-immunol-040210-092915","article-title":"Integration of genetic and immunological insights into a model of celiac disease pathogenesis","volume":"29","author":"Abadie","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.cll.2018.07.007_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.178.1.187","article-title":"Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T\u00a0cells isolated from the small intestinal mucosa of celiac disease patients","volume":"178","author":"Lundin","year":"1993","journal-title":"J\u00a0Exp Med"},{"issue":"9673","key":"10.1016\/j.cll.2018.07.007_bib28","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(09)60254-3","article-title":"Coeliac disease","volume":"373","author":"Di Sabatino","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cll.2018.07.007_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T\u00a0cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.cll.2018.07.007_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-3083.1998.00397.x","article-title":"Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition","volume":"48","author":"Sjostrom","year":"1998","journal-title":"Scand J Immunol"},{"issue":"11","key":"10.1016\/j.cll.2018.07.007_bib31","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/clinchem\/47.11.2023","article-title":"Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides","volume":"47","author":"Aleanzi","year":"2001","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.cll.2018.07.007_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2249.2007.03487.x","article-title":"Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease","volume":"150","author":"Ankelo","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.cll.2018.07.007_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.1984.tb06601.x","article-title":"IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease","volume":"111","author":"Chorzelski","year":"1984","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.cll.2018.07.007_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MPG.0b013e318216f2e5","article-title":"Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report","volume":"54","author":"Giersiepen","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"20","key":"10.1016\/j.cll.2018.07.007_bib35","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3748\/wjg.v18.i20.2511","article-title":"Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation","volume":"18","author":"Kurppa","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cll.2018.07.007_bib36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1136\/gut.33.12.1633","article-title":"Endomysial antibody: is it the best screening test for coeliac disease?","volume":"33","author":"Ferreira","year":"1992","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cll.2018.07.007_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.cll.2018.07.007_bib38","unstructured":"World gastroenterology organisation global guidelines - celiac disease. World Gastroenterology Organisation; 2016. Available at: http:\/\/www.worldgastroenterology.org\/UserFiles\/file\/guidelines\/celiac-disease-english-2016.pdf. Accessed July 3, 2018."},{"issue":"5","key":"10.1016\/j.cll.2018.07.007_bib39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and\u00a0management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cll.2018.07.007_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.cll.2018.07.007_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-0039.2011.01676.x","article-title":"Celiac disease and HLA typing using real-time PCR with melting curve analysis","volume":"78","author":"Profaizer","year":"2011","journal-title":"Tissue Antigens"},{"issue":"7","key":"10.1016\/j.cll.2018.07.007_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T\u00a0cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121831179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121831179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:38:59Z","timestamp":1775241539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027227121831179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S027227121831179X"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2018.07.007","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Human Leukocyte Antigen in Celiac Disease Diagnostics","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2018.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}